Statement Of Cash Flows

Renascience Inc. - Filing #7296926

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-72,045,000 JPY
-94,343,000 JPY
Depreciation
JPY
911,000 JPY
Decrease (increase) in trade receivables
4,400,000 JPY
JPY
Subtotal
-130,324,000 JPY
-82,324,000 JPY
Other, net
JPY
54,000 JPY
Income taxes paid
-1,979,000 JPY
-1,955,000 JPY
Net cash provided by (used in) operating activities
-132,137,000 JPY
-84,271,000 JPY
Decrease (increase) in other assets
JPY
130,000 JPY
Increase (decrease) in other liabilities
130,000 JPY
-185,000 JPY
Cash flows from operating activities
Increase (decrease) in accounts payable - other
-80,150,000 JPY
-20,937,000 JPY
Cash flows from operating activities
Cash flows from investing activities
Net cash provided by (used in) investing activities
2,250,000 JPY
JPY
Cash flows from financing activities
Proceeds from long-term borrowings
9,476,000 JPY
46,500,000 JPY
Net cash provided by (used in) financing activities
9,476,000 JPY
46,500,000 JPY
Net increase (decrease) in cash and cash equivalents
-120,411,000 JPY
-37,771,000 JPY
Cash and cash equivalents
1,525,782,000 JPY
1,646,193,000 JPY
1,794,008,000 JPY
1,831,780,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.